StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Bank of America

BUYDr. Reddy's Laboratories Limited

byBank of AmericaHorizon: NA (inferred 1 year)23 Jul 2026via NDTV Profit (Live)

Entry₹1,182.8Inferred
Target₹1,480
Total upside +25.13%
Stop lossNot given
CMP₹1,165.51h ago
Active-1.46%+26.98%upside left 10 mo left
Follow Bank of America for new callsGet alertsWatch DRREDDY for new buy/sell callsGet alertsSee 15 other Long-term calls on DRREDDYSee 1 other Long-term pick this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 14 Sept, 6:07 pm IST
7 supporting7 neutral8 opposing
Supports the BUY call (7)

Dr Reddy's Mexico API facility gets 2 observations in US FDA records assessment

NewsCnbc-Tv18·11 Sept · 2d ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·11 Aug · 1mo ago

5 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·23 Jul · 2mo ago

Neutral / worth noting (7)

USFDA Closes Dr Reddy's UK API Plant Inspection With VAI Classification

NewsGoogle News·19 Aug · 4w ago

(opens in new tab)

FDA closes Dr. Reddy’s (NYSE: RDY) UK plant inspection

NewsGoogle News·17 Aug · 4w ago

(opens in new tab)
Weighs against the BUY call (8)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·11 Sept · 3d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·10 Sept · 3d ago

(opens in new tab)

FDA flags four issues at Dr. Reddy’s (NYSE: RDY) Hyderabad plant after August inspection

NewsGoogle News·17 Aug · 4w ago

(opens in new tab)

5 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·23 Jul · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.